In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1856 News Items found
Man posing with his wife, son, and daughter.
Clinical Update
Immunotherapy After Surgery Helps Prevent Cancer Recurrence in MMRd Patients With ctDNA, MSK Study Shows

Read about clinical trial results showing that a liquid biopsy helped select cancer patients for effective immunotherapy treatment.
David and Margaret
Potential New Treatment for KRAS-GI2D Lung Cancer Reported in First-of-Its-Kind Clinical Trial

For the first time, a targeted drug is showing promise at treating non-small cell lung cancer caused by a mutation called KRAS-G12D.
Maureen Sideris is seen smiling with her sister Marion.
Using Only Immunotherapy Successfully Treats Several Cancers With MMRd Mutation, Improves Quality of Life

Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo surgery, radiation, or chemotherapy.
Dr. Elli Papaemmanuil in her lab
Why Clonal Hematopoiesis, a Blood Condition Related to Aging, Is Linked to Worse Outcomes for Cancer Patients

Researchers have shown how CH, a blood condition related to aging, affects cancer outcomes — through a phenomenon called tumor-infiltrating clonal hematopoiesis.
A pipette inserted into a tube in a rack of test tubes
A New Cellular Immunotherapy Approach May Offer Treatment for AML and MDS 

Laboratory research shows how it may be possible to develop an immunotherapy-based approach for treating aggressive forms of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
A researcher working in an MSK lab
MSK Research Highlights, April 23, 2025

New MSK research identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife. MSK clinical trials also supported the recent approval of the targeted drug larotrectinib by the FDA.
Dr. Jamie Ostroff speaks with a patient
Support
Stigma Around Lung Cancer and Smoking: Can It Be Prevented?

MSK specialists are working to help reduce the stigma around lung cancer and smoking, helping to ensure that all patients get the best care.
MSK physician-scientists Viviane Tabar and Lorenz Studer.
Potential Treatment for Parkinson’s Using Investigational Cell Therapy Shows Early Promise

Learn how a stem cell-derived treatment shows potential for treating Parkinson's disease.
The outside of the David H. Koch Center for Cancer Care at MSK
In the Clinic
The Latest Interventional Radiology Targets Liver Tumors Without Surgery 

For cancer in the liver, interventional radiology techniques can be used to destroy tumors while minimizing damage to healthy liver tissue. 
MSK President and CEO Selwyn Vickers, MD, FACS, speaking from a podium
A Message From Dr. Selwyn Vickers, MSK’s President and CEO

MSK is committed to helping people with cancer live healthier, more satisfying lives during and after treatment. So that people don’t just survive cancer — they thrive.